Exclusive: Patrick Hsu startup launches, looks beyond CRISPR for gene insertion technology
Summary by Endpoints News
1 Articles
1 Articles
All
Left
Center
Right
Exclusive: Patrick Hsu startup launches, looks beyond CRISPR for gene insertion technology
Stylus Medicine, a startup founded by Patrick Hsu, has raised $85 million to develop a suite of technologies that it believes will help solve some of the biggest and most competitive challenges in the cell and gene therapy field.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage